Immunovia AB's total assets for Q2 2025 were kr34.85M, a decrease of -20.41% from the previous quarter. SE:IMMNOV total liabilities were kr17.11M for the fiscal quarter, a 17.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.